MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Companies

Rubicon Research Private Limited

Rubicon Research Private Limited
Rubicon is a leading Drug Delivery company from India providing cost effective, world class product development solutions. We outlicense innovative products and offer contract research services.

The company in detail

Profile

At Rubicon Research we are dedicated to pharmaceutical development sciences especially in the area of formulation research. We house end-to-end capabilities and offers contract research services in design of dosage forms, formulation development, analytical methods development and validations, and stability studies to supply of clinical trial materials. Rubicon offers an assured supply chain stream to its clients Through its state-of-art cGMP manufacturing facility.

Rubicon has developed and patented drug delivery technologies that can be applied to overcome commonly faced formulation challenges like low bioavailability; gastric retention, bitter taste; poor stability. Rubicon offers design of customized release profiles, orally disintegrating tablet and other product life cycle management options. Using platform technologies, Rubicon has developed innovative and value added product offerings for out licensing.

Rubicon offers documents in CTD format in compliance with global regulatory requirements.

Partnering strategy/interests

Rubicon is interested in following partnering strategies :

  1. Out Licensing of its products for upfront payment + Royalties +/ Supply chain

  2. Fee for service for Contract research in Formulation development and analytical studies including stand alone stability studies

  3. Manufacturing and packaging of Clinical Trial Supplies

  4. Supply chain agreements for niche products

Out-licensing

Rubicon has developed a pleasant tasting, robust, orodispersible tablet which can be packed in unit dose blister packs. This provides an excellent opportunity for product differentiation due to improved patient convenience. More
Rubicon has developed Ropinirole XL using its proprietary technology having freedom to operate.The technology provides a non swelling dosage form with pH independent drug release with positive corelation in invivo pilot biostudy. More
Rubicon has developed a Controlled Release Tablet of Vitamin C using its patented technology that ensures steady release of Vitamin C over 12 hours. The flavored coating provides a pleasant swallowing experience. More

Contact details

Mr Nilesh Nayak
Sr.Executive Business Development
Business Development

Contact directly

Full contact list

Head office

Rubicon Research Private Limited
221, Annexe Building,
Goregaon Mulund Link Road
Off LBS Marg
Bhandup Mumbai
Mumbai
400078
India

Company figures

Formed: 1999
Number of employees: 150

Related categories

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioPartnering America
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us